Industry News
'Irrefutable' evidence that colorectal cancer screening has led to fall in death rates
Oct 01, 2013
Screening for colorectal cancer (CRC) in European countries is highly effective in reducing mortality from the disease... Read More
Scientists erase brain tumor cells in mice
Oct 01, 2013
Scientists have discovered that a repurposed drug approved by the US Food and Drug Administration (FDA) is capable of erasing brain tumor cells in mice. This is according to a study published in the journal Oncotarget... Read More
Survival in head and neck cancer patients improved using hyperfractionated radiotherapy
Oct 01, 2013
The use of an intensified form of radiotherapy in patients with locally advanced head and neck cancers can improve overall survival rates compared with standard radiation therapy, according to results from a large study to be presented at the 2013 European Cancer Congress (ECC2013) [1]... Read More
Association between survival after cancer diagnosis in Europe and amount governments spend on health care
Oct 01, 2013
The more an EU (European Union) national government spends on health, the fewer the deaths after a cancer diagnosis in that country, according to new research to be presented to the 2013 European Cancer Congress (ECC2013) [1] today (Sunday) and published simultaneously in the leading cancer journal Annals of Oncology [2]... Read More
Breast cancer: 'critical gaps' found in research
Oct 01, 2013
A new study published in the journal Breast Cancer Research has identified 10 "critical gaps" that exist in the research of the disease, which could see the loss of hundreds of thousands of lives if not addressed urgently... Read More
Improved survival in breast cancer through early treatment of chest lymph nodes
Oct 01, 2013
Giving radiation therapy to the lymph nodes located behind the breast bone and above the collar bone to patients with early breast cancer improves overall survival without increasing side effects... Read More
New imaging technique could cut down on false positives in breast cancer screening
Oct 01, 2013
A joint BYU-Utah research team is developing a new breast cancer screening technique that has the potential to reduce false positives, and, possibly, minimize the need for invasive biopsies... Read More
Lung cancer drug doing well in smoker trial
Sep 30, 2013
Early results of a trial testing the safety of a new type of drug that helps the immune system attack cancer cells is showing promising results in lung cancer patients, especially in those who are smokers or former smokers. The experimental drug, called MPDL3280A (made by Roche), is being tested in patients with non-small cell lung cancer (NSCLC)... Read More
LEO Pharma announce the completion of the Phase III FIELD Study 1, evaluating one year treatment outcomes of actinic keratosis
Sep 30, 2013
LEO Pharma has announced the completion of the Phase III FIELD Study 1 - the largest[1-3] ever, one year evaluation of field treatment with ingenol mebutate gel for actinic keratosis (AK) after initial cryosurgery of individual AK lesions, compared to cryosurgery followed by a vehicle gel... Read More
Lung cancer drug doing well in smoker trial
Sep 30, 2013
Early results of a trial testing the safety of a new type of drug that helps the immune system attack cancer cells is showing promising results in lung cancer patients, especially in those who are smokers or former smokers. The experimental drug, called MPDL3280A (made by Roche), is being tested in patients with non-small cell lung cancer (NSCLC)... Read More
Previous Page Next Page